{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T01:02:54Z","timestamp":1780966974798,"version":"3.54.1"},"reference-count":44,"publisher":"BMJ","issue":"2","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Med Genet"],"accepted":{"date-parts":[[2017,8,28]]},"published-print":{"date-parts":[[2018,2]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Identification of CNVs through chromosomal microarray (CMA) testing is the first-line investigation in individuals with learning difficulties\/congenital abnormalities. Although recognised that CMA testing may identify CNVs encompassing a cancer predisposition gene (CPG), limited information is available on the frequency and nature of such results.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We investigated CNV gains and losses affecting 39 CPGs in 3366 pilot index case individuals undergoing CMA testing, and then studied an extended cohort (n=10\u2009454) for CNV losses at 105 CPGs and CNV gains at 9 proto-oncogenes implicated in inherited cancer susceptibility.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>In the pilot cohort, 31\/3366 (0.92%) individuals had a CNV involving one or more of 16\/39 CPGs. 30\/31 CNVs involved a tumour suppressor gene (TSG), and 1\/30 a proto-oncogene (gain of <jats:italic>MET<\/jats:italic>). <jats:italic>BMPR1A<\/jats:italic>, <jats:italic>TSC2<\/jats:italic> and <jats:italic>TMEM127<\/jats:italic> were affected in multiple cases. In the second stage analysis, 49\/10 454 (0.47%) individuals in the extended cohort had 50 CNVs involving 24\/105 CPGs. 43\/50 CNVs involved a TSG and 7\/50 a proto-oncogene (4 gains, 3 deletions). The most frequently involved genes, <jats:italic>FLCN<\/jats:italic> (n=10) and <jats:italic>SDHA<\/jats:italic> (n=7), map to the Smith-Magenis and cri-du-chat regions, respectively.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Incidental identification of a CNV involving a CPG is not rare and poses challenges for future cancer risk estimation. Prospective data collection from CPG-CNV cohorts ascertained incidentally and through syndromic presentations is required to determine the risks posed by specific CNVs. In particular, ascertainment and investigation of adults with CPG-CNVs and adults with learning disability and cancer, could provide important information to guide clinical management and surveillance.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/jmedgenet-2017-104892","type":"journal-article","created":{"date-parts":[[2017,9,16]],"date-time":"2017-09-16T20:11:31Z","timestamp":1505592691000},"page":"89-96","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":9,"title":["CNVs affecting cancer predisposing genes (CPGs) detected as incidental findings in routine germline diagnostic chromosomal microarray (CMA) testing"],"prefix":"10.1136","volume":"55","author":[{"given":"Josie","family":"Innes","sequence":"first","affiliation":[{"name":"Manchester Centre for Genomic Medicine, Manchester Centre for Genomic Medicine, St Mary\u2019s Hospital, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Reali","sequence":"additional","affiliation":[{"name":"West Midlands Regional Genetics Service, Birmingham Women\u2019s and Children\u2019s NHS Foundation Trust, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill","family":"Clayton-Smith","sequence":"additional","affiliation":[{"name":"Manchester Centre for Genomic Medicine, Manchester Centre for Genomic Medicine, St Mary\u2019s Hospital, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgina","family":"Hall","sequence":"additional","affiliation":[{"name":"Manchester Centre for Genomic Medicine, Manchester Centre for Genomic Medicine, St Mary\u2019s Hospital, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek HK","family":"Lim","sequence":"additional","affiliation":[{"name":"West Midlands Regional Genetics Service, Birmingham Women\u2019s and Children\u2019s NHS Foundation Trust, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George J","family":"Burghel","sequence":"additional","affiliation":[{"name":"Manchester Centre for Genomic Medicine, Manchester Centre for Genomic Medicine, St Mary\u2019s Hospital, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"French","sequence":"additional","affiliation":[{"name":"Manchester Centre for Genomic Medicine, Manchester Centre for Genomic Medicine, St Mary\u2019s Hospital, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Unzela","family":"Khan","sequence":"additional","affiliation":[{"name":"Manchester Centre for Genomic Medicine, Manchester Centre for Genomic Medicine, St Mary\u2019s Hospital, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Walker","sequence":"additional","affiliation":[{"name":"Manchester Centre for Genomic Medicine, Manchester Centre for Genomic Medicine, St Mary\u2019s Hospital, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Lalloo","sequence":"additional","affiliation":[{"name":"Manchester Centre for Genomic Medicine, Manchester Centre for Genomic Medicine, St Mary\u2019s Hospital, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8482-5784","authenticated-orcid":false,"given":"D Gareth R","family":"Evans","sequence":"additional","affiliation":[{"name":"Manchester Centre for Genomic Medicine, Manchester Centre for Genomic Medicine, St Mary\u2019s Hospital, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic","family":"McMullan","sequence":"additional","affiliation":[{"name":"West Midlands Regional Genetics Service, Birmingham Women\u2019s and Children\u2019s NHS Foundation Trust, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eamonn R","family":"Maher","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, University of Cambridge and NIHR Cambridge Biomedical Research Centre and Cancer Research UK Cambridge Centre, Cambridge, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma R","family":"Woodward","sequence":"additional","affiliation":[{"name":"Manchester Centre for Genomic Medicine, Manchester Centre for Genomic Medicine, St Mary\u2019s Hospital, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2017,9,16]]},"reference":[{"key":"2025100521084000000_55.2.89.1","doi-asserted-by":"publisher","DOI":"10.1038\/nature05329"},{"key":"2025100521084000000_55.2.89.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2010.04.006"},{"key":"2025100521084000000_55.2.89.3","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.2010.087593"},{"key":"2025100521084000000_55.2.89.4","unstructured":"illumina. Reagent and Library Prep Kit Bundles Available for the MiniSeq System. 2017 http:\/\/www.illumina.com\/products\/trusight_cancer.html (accessed 21 Jun 2017)."},{"key":"2025100521084000000_55.2.89.5","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0603877103"},{"key":"2025100521084000000_55.2.89.6","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-14-1096"},{"key":"2025100521084000000_55.2.89.7","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddw057"},{"key":"2025100521084000000_55.2.89.8","doi-asserted-by":"publisher","DOI":"10.1007\/s00109-012-0967-z"},{"key":"2025100521084000000_55.2.89.9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1110000"},{"key":"2025100521084000000_55.2.89.10","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2003.10.079"},{"key":"2025100521084000000_55.2.89.11","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/ng.2503","article-title":"Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas","volume":"45","author":"Palles","year":"2013","journal-title":"Nat Genet"},{"key":"2025100521084000000_55.2.89.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2010.01.013"},{"key":"2025100521084000000_55.2.89.13","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2931"},{"key":"2025100521084000000_55.2.89.14","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2552"},{"key":"2025100521084000000_55.2.89.15","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddq206"},{"key":"2025100521084000000_55.2.89.16","doi-asserted-by":"publisher","DOI":"10.1038\/nature07261"},{"key":"2025100521084000000_55.2.89.17","doi-asserted-by":"publisher","DOI":"10.1038\/ng1671"},{"key":"2025100521084000000_55.2.89.18","doi-asserted-by":"publisher","DOI":"10.1038\/ng1641"},{"key":"2025100521084000000_55.2.89.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2011.12.008"},{"key":"2025100521084000000_55.2.89.20","doi-asserted-by":"publisher","DOI":"10.1038\/ng0196-97"},{"key":"2025100521084000000_55.2.89.21","doi-asserted-by":"publisher","DOI":"10.1038\/1209"},{"key":"2025100521084000000_55.2.89.22","doi-asserted-by":"publisher","DOI":"10.1038\/ng0597-68"},{"key":"2025100521084000000_55.2.89.23","doi-asserted-by":"publisher","DOI":"10.1038\/363458a0"},{"key":"2025100521084000000_55.2.89.24","unstructured":"Decipher. Genome Browser. 2017 https:\/\/decipher.sanger.ac.uk\/browser (accessed 21 June 2017)."},{"key":"2025100521084000000_55.2.89.25","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1002\/ajmg.a.33023","article-title":"Genotype-phenotype correlations in VHL exon deletions","volume":"149A","author":"McNeill","year":"2009","journal-title":"Am J Med Genet A"},{"key":"2025100521084000000_55.2.89.26","first-page":"940","article-title":"The spectrum of RB1 germ-line mutations in hereditary retinoblastoma","volume":"58","author":"Lohmann","year":"1996","journal-title":"Am J Hum Genet"},{"key":"2025100521084000000_55.2.89.27","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/humu.22938","article-title":"The Contribution of Whole Gene Deletions and Large Rearrangements to the Mutation Spectrum in Inherited Tumor Predisposing Syndromes","volume":"37","author":"Smith","year":"2016","journal-title":"Hum Mutat"},{"key":"2025100521084000000_55.2.89.28","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/bjs.9693","article-title":"Genotype-defined cancer risk in juvenile polyposis syndrome","volume":"102","author":"Aytac","year":"2015","journal-title":"Br J Surg"},{"key":"2025100521084000000_55.2.89.29","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddq366"},{"key":"2025100521084000000_55.2.89.30","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.ajhg.2016.08.022","article-title":"Structural Chromosomal Rearrangements Require Nucleotide-Level Resolution: Lessons from Next-Generation Sequencing in Prenatal Diagnosis","volume":"99","author":"Ordulu","year":"2016","journal-title":"Am J Hum Genet"},{"key":"2025100521084000000_55.2.89.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2010.11.024"},{"key":"2025100521084000000_55.2.89.32","doi-asserted-by":"publisher","DOI":"10.1002\/humu.20227"},{"key":"2025100521084000000_55.2.89.33","doi-asserted-by":"publisher","DOI":"10.1007\/s00439-006-0308-9"},{"key":"2025100521084000000_55.2.89.34","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.2007.052506"},{"key":"2025100521084000000_55.2.89.35","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2009.542"},{"key":"2025100521084000000_55.2.89.36","first-page":"3098","article-title":"3 Cases of Partial Deletion of the Short Arm of a 5 Chromosome","volume":"257","author":"Lejeune","year":"1963","journal-title":"C R Hebd Seances Acad Sci"},{"key":"2025100521084000000_55.2.89.37","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.1320240303"},{"key":"2025100521084000000_55.2.89.38","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.38.3.151"},{"key":"2025100521084000000_55.2.89.39","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/mgg3.279","article-title":"SDHA related tumorigenesis: a new case series and literature review for variant interpretation and pathogenicity","volume":"5","author":"Casey","year":"2017","journal-title":"Mol Genet Genomic Med"},{"key":"2025100521084000000_55.2.89.40","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1001\/jamaoncol.2017.0223","article-title":"Clinical Characterization of the Pheochromocytoma and Paraganglioma Susceptibility Genes SDHA, TMEM127, MAX, and SDHAF2 for Gene-Informed Prevention","volume":"3","author":"Bausch","year":"2017","journal-title":"JAMA Oncol"},{"key":"2025100521084000000_55.2.89.41","first-page":"1","article-title":"Neoplasia in Cri du Chat Syndrome from Italian and German Databases","volume":"2017","author":"Guala","year":"2017","journal-title":"Case Rep Genet"},{"key":"2025100521084000000_55.2.89.42","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(09)70188-3"},{"key":"2025100521084000000_55.2.89.43","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.ejmg.2016.09.005","article-title":"Bilateral renal tumors in an adult man with Smith-Magenis syndrome: The role of the FLCN gene","volume":"59","author":"Dardour","year":"2016","journal-title":"Eur J Med Genet"},{"key":"2025100521084000000_55.2.89.44","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2012.95"}],"container-title":["Journal of Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jmedgenet-2017-104892","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T04:08:52Z","timestamp":1759723732000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmg.bmj.com\/lookup\/doi\/10.1136\/jmedgenet-2017-104892"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,16]]},"references-count":44,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,1,23]]},"published-print":{"date-parts":[[2018,2]]}},"alternative-id":["10.1136\/jmedgenet-2017-104892"],"URL":"https:\/\/doi.org\/10.1136\/jmedgenet-2017-104892","relation":{},"ISSN":["0022-2593","1468-6244"],"issn-type":[{"value":"0022-2593","type":"print"},{"value":"1468-6244","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,16]]}}}